The ATS has developed these instructions to assist you in the preparation of your session for the ATS International Conference. Please review them carefully. If someone other than yourself will be developing the program and inviting the speakers, please contact the ATS at 212-315-8659 or firstname.lastname@example.org so we can reassign the online workform.
International Conference planners and presenters have diverse interests and relationships that contribute to the success of the Conference but may also cause “conflicts of interest” (COI) that must be disclosed and managed to comply with Accreditation Council on Continuing Medical Education (ACCME) requirements. ATS COI management strives to ensure public confidence in the scientific integrity of ATS activities, not to create barriers to collaboration between clinician-scientists and industry. To accomplish this in the context of a large number of Conference sessions and diverse topics, ATS must rely heavily on each Program Committee, session organizer, chair, and speaker.
Please ensure that the following requirements are met as you organize and carry out your session:
- Independence, balance and scientific rigor.
- All participants in official ATS activities, including conference session organizers and speakers, are required to uphold the highest standards of professionalism and ethical conduct.*
- Content must provide objective information based on scientific methods generally accepted in the medical community, and be free of commercial bias.
- Data presented should not be outdated
- A balanced view of therapeutic options
- Use of generic names will contribute to this impartiality and is preferred. If the presentation requires trade names, where available trade names from several companies should be used.
- Disclosure of potential conflicts of interests (COI) to ATS and learners, achieved by having all session chairs and presenters complete the online 2017 ATS COI questionnaire by ATS deadline, all session chairs use the ATS COI website to review their presenters’ disclosures, and all presenters show a self-prepared disclosure slide at start of his/her presentation onsite (see below.)
- Disclosure of any “off-label” uses of substances or products cited in the presentation (i.e., uses not approved in the United States), and/or the status of substances or products that are being investigated for such use, is also required.
*See the related ATS policy at http://conference.thoracic.org/speakers/index.php
The ATS reserves the right to seek corporate support in the form of educational grants for all the programs accepted for presentation at the International Conference. These grants are in support of the International Conference and are sought after sessions are approved and final programs are submitted. The grant relationship is between the American Thoracic Society and the supporting companies. Supporters have no input into the content of the program. The grants will not affect the disclosures of the faculty relationships with commercial interests.
Upon session approval, you are responsible for determining and inviting each presenter (speaker) in your session, confirming their participation, and submitting the required Session Workform by October 17, 2016 (see next page for details). When arranging your speakers, please:
- First look to the ATS Membership when choosing the speakers for your session.
- Be sure the content of each presentation complements the other presentations and that there are no overlaps.
- Notify each speaker of the date/time and length/title of their presentation.
- Stress the importance of adhering to their schedule.
- Share the objectives and target audience with your speakers for a better understanding of the session.
- Manage potential conflicts of interest as outlined on the next page
MANAGING CONFLICTS OF INTEREST (COI):
Prior to Submitting the Session Workform:
- Prior to inviting a prospective speaker, session organizers/chairs informally consider whether there are any circumstances that could be perceived as causing a significant, relevant conflict of interest, and if so, structure the session and speaker’s role to resolve the issue according to ATS recommendations and ACCME requirements.*.
- Please note:
- ATS COI management exists to ensure public confidence in the scientific integrity of ATS activities, not to create barriers to collaboration between clinician-scientists and industry. The ACCME prohibits the use of employees of commercial interests such as medical device manufacturers and pharmaceutical companies as presenters in accredited CME activities if the content of CME that the employee controls relates to the business lines and products of the employer. Any sessions accepted by ATS that do not meet this requirement will not be eligible for CME credit. ATS staff will contact organizers/chairs that state on their workform that involvement of an industry scientist is necessary to discuss options.
- The ATS prohibits persons affiliated with the tobacco industry from organizing, chairing or presenting at conference sessions.
*See ATS COI management details at http://conference.thoracic.org/speakers/index.php
Formal Disclosure to ATS and Learners by Session Chairs and Presenters and Formal Review of Potential COI
- After ATS receives the names of confirmed speakers, Session Chairs and speakers will be sent instructions to complete or update the online ATS disclosure questionnaire by the end of January 2017* and prepare a disclosure slide to be shown onsite at the start of presentations.
- Session chairs will also be instructed to use the ATS COI website during February 2017 to review summaries of the disclosures of each speaker in your session and use a simple drop-down menu to evaluate all relevant potential conflicts and confirm they will be managed according to requirements. Chairs can contact ATS COI Staff if they need assistance. Staff will contact you as the Program Committee Chair of the sponsoring Assembly if the session organizer and staff are unable to resolve a matter.
* Disclosure and review of speaker changes made past these deadlines will be arranged separately.
You must submit the session workform confirming all session and speaker information. Completed workforms must be submitted online by Monday, October 17, 2016.
To submit your session work form:
- go to the International Conference website: https://cms.psav.com/cPaper/ats2017
- log into the site by using the username and password used when submitting your original proposal
In addition to the COI disclosure process noted earlier, all ATS 2017 session chairs and faculty will also be instructed to:
- Register for the conference. (All speakers must personally register.)
- Complete an online Presentation Recording Permission form.
- Prepare a PowerPoint presentation, including a disclosure slide to show at start of presentation.* In order to keep the talk on schedule, consider including slides based on one slide per minute.
- Consult the Procedures for Electronic Presentations available on the ATS website.
- Refrain from using industry logos or brand names in PowerPoint presentations
- Upload PowerPoint presentations (including disclosure slide) online according to ATS instructions
- Visit the Speaker Ready Room onsite to be sure your presentation is running correctly
*Template available at http://conference.thoracic.org/speakers/index.php
All chairs and speakers must register for the conference through the regular registration process.
Presentation and Conference Attendance:
- ATS member speakers are required to pay the member general registration fee and respective fees for courses, seminars and workshops accordingly.
- Non-member speakers who plan to attend the full conference are required to pay a discounted non-member general registration fee and respective fees for courses, seminars and workshops accordingly.
- Non-member speakers planning to attend the conference just for the purpose of giving their presentation, and do not plan to attend the other conference sessions, are eligible to register for a one-day complimentary pass.